Patient P-01329
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
24%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 NBL-101 started — Baseline state S08
- Day 30 BR-03 recommended — Behavioural Recommendation BR-03
- Day 31 Patient accepted — Started BR-03 in the companion
- Day 38 GI symptom burden −11% vs expected — Behavioural Recommendation BR-03
- Day 44 Tolerance state changed — Unstable → Improving
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability+8
- Inflammatory activity+5
- Nutritional resilience-3
- Toxicity+2
What helped?
- Behavioural Recommendation BR-03Day 30Result: symptom burden −11%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
GI burden
Companion20.1/100
worsening · +0.8 vs previous 14 d
Toxicity
Blood22.6/100
worsening · +1.7 vs previous 14 d
Sleep quality
Wearable31/100
worsening · -3.0 vs previous 14 d
Energy level
Daily log5.8/10
worsening · -0.3 vs previous 14 d
Stress level
Daily log4.1/10
worsening · +0.2 vs previous 14 d
Steps
Wearable4,672
improving · +411 vs previous 14 d
Adherence
Companion95.8 %
stable · -1.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 84 from the failing basin, 6 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More simple carbsGI -2.6 next day on high-intake days · n 18
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Simple carbohydrates-2.6supporter · 69%
- Dietary fat load+1.4no signal · 38%
- Insoluble fibre+1.1no signal · 28%
- Histamine load+1no signal · 15%
- Spicy / capsaicin-0.8no signal · 17%
- Alcohol+0.4no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓20
- WearableShort sleep window
- Mucosal barrier integrity ↓10
- WearableSleep 5.7 h, below personal baseline
DNA
Fictional pharmacogenomic panel
- CYP2D6 Normal metabolizerExpected exposure
Microbiome
Shannon diversity 3.3 · butyrate capacity 59/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 51 ms
- Sleep
- 5.8 h
- Steps
- 5,464
- Resting HR
- 63 bpm
Daily log: GI score 20, nutritional resilience 66, adherence 96.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the scheduled dose as agreed with your care team
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-01766 | 48% | S05 | AD-05 | no change | 90 |
| P-01804 | 30% | S19 | AD-05 | improved | 61 |
| P-01541 | 26% | S09 | AD-05 | no change | 43 |
| P-01495 | 42% | S07 | BR-03 | improved | 85 |
| P-01677 | 40% | S05 | BR-03 | no change | 86 |
| P-01654 | 45% | S08 | CR-01 | improved | 85 |
| P-01430 | 26% | S05 | CR-01 | improved | 54 |
| P-01479 | 41% | S15 | DT-01 | improved | 84 |
| P-01855 | 38% | S04 | DT-01 | improved | 73 |
| P-01724 | 31% | S10 | DT-01 | improved | 63 |
| P-01767 | 31% | S14 | DT-01 | no change | 63 |
| P-01522 | 28% | S06 | DT-01 | no change | 62 |